Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-210355
Filing Date
2026-05-07
Accepted
2026-05-07 07:30:40
Documents
64
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rapp-20260331.htm   iXBRL 10-Q 2420398
2 EX-10.1 rapp-ex10_1.htm EX-10.1 76559
3 EX-31.1 rapp-ex31_1.htm EX-31.1 19325
4 EX-31.2 rapp-ex31_2.htm EX-31.2 18171
5 EX-32.1 rapp-ex32_1.htm EX-32.1 16175
  Complete submission text file 0001193125-26-210355.txt   8982683

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapp-20260331.xsd EX-101.SCH 1300776
68 EXTRACTED XBRL INSTANCE DOCUMENT rapp-20260331_htm.xml XML 1437115
Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42121 | Film No.: 26950887
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)